SGRY
Surgery Partners, Inc. Common Stock
SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Surgery Partners (SGRY) Stock: Buy, Sell, or Hold?
$26.66
-0.07 (-0.26%)
▼
5d:
+15.11%
30d:
+83.23%
90d:
+75.51%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 09, 2026
0d
Protect SGRY Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (5%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$14.09 – $23.78
Position: EXTENDED
Forward P/E & Valuation
171.8x
STRETCHED
vs 32.5x historical avg
Wall Street Target
$22.90
-14.1% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$23.12 / $27.23
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: SGRY is 12.1% above its trading range ($23.78). Market expects 74.3% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $26.66, which is considered extended relative to its 30-day fair value range of $14.09 to $23.78. From a valuation perspective, the stock is trading at a premium (Forward PE: 171.8) compared to its historical average (32.5). At these levels, the market is pricing in 74.3% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, SGRY is in a uptrend. The price is approaching resistance at $27.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGRY scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $22.90. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SGRY is in a uptrend. The price is approaching resistance at $27.23. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SGRY scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $22.90. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$14.09 -
$23.78
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
4.8%
Trading Range & Key Levels
30-Day Trading Range
$14.09 -
$23.78
Current vs Trading Range
EXTENDED
Support Level
$23.12
Resistance Level
$27.23
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
SGRY is technically overbought (RSI 90). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+12.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 14.1% above Wall St target ($22.90)
- BEARISH: Market expects 74.3% growth - appears too optimistic based on history
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
171.78
Wall Street Target
$22.90
(-14.1%)
Revenue Growth (YoY)
-0.8%
Profit Margin
-2.6%
Valuation Premium vs History
+74.3% premium
PE vs Historical
171.8 vs 32.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+74.3%
(market-implied from PE analysis)
1-Year Target
$39.99
(+50%)
2-Year Target
$59.99
(+125%)
3-Year Target
$89.98
(+238%)
3-Yr Target (if PE normalizes)
(PE: 172→33)
PE COMPRESSION
$17.02
(-36%)
Significant PE compression expected
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 171.8, Growth: -47.4%)
$19.44
(+-27%)
Base:
(SPY PE: 19.9, Growth: -47.4%)
$2.25
(-92%)
Bear:
(PE: 16.9, Growth: -47.4%)
$1.91
(-93%)
Share SGRY Analysis
Share this live SGRY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SGRY)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary:
Healthcare stocks were softer late Monday afternoon, but $SGRY defied the trend with a significant gain of 47% following a takeover deal announcement.
Key Retail Themes:
M&A activity
Healthcare sector performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:00 PM ET
Data refreshes hourly during market hours. Next update: 9:00 PM
Data refreshes hourly during market hours. Next update: 9:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 50 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 34 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 36 SELL |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SGRY Research Pages
